Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Millan

Showing results (41-50 of 188) with videos related to

Pageof 19
Sort By:
Psychopharmacology|May 2, 2003
Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypesMark J Millan, Sylvie Veiga, Sylvie Girardon, et al.
Psychopharmacology|December 24, 2003
Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapineAndrew J Goudie, Judith A Smith, Mark J Millan
Psychopharmacology|August 4, 2004
Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockadeMark J Millan, Mauricette Brocco, Alain Gobert, et al.
Progress in Neurobiology|July 9, 2016
Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistryPhilippe De Deurwaerdère, Giuseppe Di Giovanni, Mark J Millan
Journal of Neuroscience Methods|December 14, 2004
Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptorsAlain Gobert, Rodolphe Billiras, Laetitia Cistarelli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
The selective serotonin(2A) receptor antagonist, MDL100,907, elicits a specific interoceptive cue in ratsAnne Dekeyne, Loretta Iob, Patrick Hautefaye, et al.
Experimental Neurology|July 4, 2006
Actions at sites other than D(3) receptors mediate the effects of BP897 on l-DOPA-induced hyperactivity in monoamine-depleted ratsNaomi P Visanji, Mark J Millan, Jonathan M Brotchie
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 17, 2009
Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopramRobert L Gannon, Jean-Louis Peglion, Mark J Millan
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 7, 2014
Effects of systemically applied nAChRα7 agonists and antagonists on light-induced phase shifts of hamster circadian activity rhythmsRobert L Gannon, David A Garcia, Mark J Millan
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2014
Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulationRoberto Maggio, Marco Scarselli, Marta Capannolo, et al.
Pageof 19

Showing results (41-50 of 188) with videos related to

Sort By:
Pageof 19
Psychopharmacology|May 2, 2003
Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypesMark J Millan, Sylvie Veiga, Sylvie Girardon, et al.
Psychopharmacology|December 24, 2003
Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapineAndrew J Goudie, Judith A Smith, Mark J Millan
Psychopharmacology|August 4, 2004
Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockadeMark J Millan, Mauricette Brocco, Alain Gobert, et al.
Progress in Neurobiology|July 9, 2016
Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistryPhilippe De Deurwaerdère, Giuseppe Di Giovanni, Mark J Millan
Journal of Neuroscience Methods|December 14, 2004
Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptorsAlain Gobert, Rodolphe Billiras, Laetitia Cistarelli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
The selective serotonin(2A) receptor antagonist, MDL100,907, elicits a specific interoceptive cue in ratsAnne Dekeyne, Loretta Iob, Patrick Hautefaye, et al.
Experimental Neurology|July 4, 2006
Actions at sites other than D(3) receptors mediate the effects of BP897 on l-DOPA-induced hyperactivity in monoamine-depleted ratsNaomi P Visanji, Mark J Millan, Jonathan M Brotchie
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 17, 2009
Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopramRobert L Gannon, Jean-Louis Peglion, Mark J Millan
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 7, 2014
Effects of systemically applied nAChRα7 agonists and antagonists on light-induced phase shifts of hamster circadian activity rhythmsRobert L Gannon, David A Garcia, Mark J Millan
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2014
Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulationRoberto Maggio, Marco Scarselli, Marta Capannolo, et al.
Pageof 19